Paper Details
- Home
- Paper Details
Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder.
Author: BroffmanAndi, CampbellAimee N C, LuoSean X, NunesEdward V, PavlicovaMartina, SaxonAndrew J, ScodesJennifer, ShulmanMatisyahu
Original Abstract of the Article :
OBJECTIVE: Opioid use disorder (OUD) is associated with chronic pain. We investigated the association between medication treatments for OUD and pain in a post-hoc secondary analysis of a randomized trial of methadone versus buprenorphine/naloxone. METHODS: 1241 individuals with OUD participated in ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/32039934
データ提供:米国国立医学図書館(NLM)
Pain and Opioid Use Disorder: A Complex Relationship
Opioid use disorder (OUD) is a multifaceted challenge with profound implications for both physical and mental health. This post-hoc secondary analysis of a large randomized trial explored the association between medication treatments for OUD and pain, a prevalent co-occurring condition. The researchers examined data from 1241 individuals with OUD who participated in a pragmatic trial comparing methadone and buprenorphine/naloxone, two commonly used medications for OUD management. They investigated the relationship between pain at baseline, treatment assignment, and treatment retention, analyzing the impact of pain on treatment outcomes.
Pain as a Factor in OUD Treatment: A Complex Picture
The study's findings revealed that almost half of the participants reported pain at baseline. While pain at baseline did not significantly impact treatment retention, the study found that improvement in pain at week 4 was associated with significantly greater odds of being retained at week 24. This suggests that early pain relief may play a crucial role in maintaining treatment engagement and improving long-term outcomes for individuals with OUD. The study did not find significant differences in pain improvement between the two treatment arms, indicating that both methadone and buprenorphine/naloxone can be effective in managing pain.
Addressing Pain in OUD Treatment: A Multifaceted Approach
This study underscores the importance of addressing pain in the context of OUD treatment. Early pain management can contribute to increased treatment retention and potentially improve overall outcomes. This emphasizes the need for a comprehensive approach that addresses both substance use and pain management, ensuring the holistic well-being of individuals with OUD. Just as a camel adapts to the harsh desert environment, individuals with OUD require tailored strategies that cater to their specific needs.
Dr. Camel's Conclusion
This study highlights the intricate relationship between pain and OUD, emphasizing the importance of addressing both aspects for optimal treatment outcomes. Just as a camel relies on its strength and resilience to navigate the desert, individuals with OUD require comprehensive care that addresses their physical and mental health needs. This research underscores the value of tailoring treatment plans to individual needs, fostering a path towards recovery and well-being.
Date :
- Date Completed 2021-06-24
- Date Revised 2022-10-05
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.